Rapid method of interrupting the narcotic addiction syndrome
CA 1237986 A · Owner: Lotsof, Howard S. · Inventors: Lotsof, Howard S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The administration to a heroin addict of ibogaine ibogaine HCl or other non toxic salts of ibogaine an, alkaloid of the family apocynaceae has been discovered to, unexpectedly interrupt the physiological and psychological aspect of the opiate addiction syndrome. A single treatment was effective for about 6 months, and a series of 4 treatments was effective for approximately 3 years. The treatments consisted of the oral administration of ibogaine or its salts in dosage ranges of 6 mg/kg to 19 mg/kg. The minimum effective dose was 400 mgs and dosage increases above 1000 mgs were found to be unnecessary. Treatments were effective in 71% of the cases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted June 14, 1988. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 14, 2005.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.